IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 139 filers reported holding IMMUNOGEN INC in Q3 2013. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $5,129,000 | -42.2% | 2,514,221 | -24.1% | 0.00% | -50.0% |
Q3 2016 | $8,873,000 | -7.4% | 3,310,737 | +6.4% | 0.00% | 0.0% |
Q2 2016 | $9,583,000 | -64.8% | 3,111,490 | -2.6% | 0.00% | -66.7% |
Q1 2016 | $27,215,000 | -36.0% | 3,194,295 | +2.0% | 0.01% | -40.0% |
Q4 2015 | $42,514,000 | +35.0% | 3,132,970 | -4.5% | 0.01% | +25.0% |
Q3 2015 | $31,502,000 | -31.0% | 3,281,417 | +3.3% | 0.01% | -27.3% |
Q2 2015 | $45,674,000 | +55.8% | 3,176,229 | -3.0% | 0.01% | +57.1% |
Q1 2015 | $29,315,000 | +51.1% | 3,275,470 | +3.0% | 0.01% | +40.0% |
Q4 2014 | $19,399,000 | -37.3% | 3,180,214 | +8.9% | 0.01% | -44.4% |
Q3 2014 | $30,935,000 | -11.0% | 2,921,181 | -0.4% | 0.01% | -10.0% |
Q2 2014 | $34,761,000 | -26.9% | 2,933,416 | -7.9% | 0.01% | -28.6% |
Q1 2014 | $47,562,000 | +4.7% | 3,185,688 | +2.9% | 0.01% | 0.0% |
Q4 2013 | $45,432,000 | -15.2% | 3,096,905 | -1.6% | 0.01% | -22.2% |
Q3 2013 | $53,556,000 | +17.7% | 3,146,627 | +14.8% | 0.02% | +5.9% |
Q2 2013 | $45,487,000 | – | 2,741,850 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
Northeast Financial Consultants Inc | 34,315 | $133,000 | 0.06% |